KENNETH ERLAND JOHNSON

Insider Reports History

Location
Chicago, IL
Signature
/s/ Beth Hecht, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by KENNETH ERLAND JOHNSON:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Senior Vice President, Global Development and Medical Affairs Common Stock 320,446 $1,140,788 $3.56 31 Jan 2025 Direct
XERIS PHARMACEUTICALS INC Sr. VP Clinical Development, Regulatory, Quality Assurance & Medical Affairs Common Stock 0 05 Oct 2021 Direct
XERIS PHARMACEUTICALS INC Sr. VP Clinical Development, Regulatory, Quality Assurance & Medical Affairs Stock Option (Right to Buy) 0 05 Oct 2021 Direct

Insider Reports Filed by KENNETH ERLAND JOHNSON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XERS Xeris Biopharma Holdings, Inc. 31 Jan 2025 2 -$147,092 4 Senior Vice President, Global Development and Medical Affairs 03 Feb 2025, 19:39
XERS Xeris Biopharma Holdings, Inc. 03 Jan 2025 1 -$44,768 4 Senior Vice President, Global Development and Medical Affairs 07 Jan 2025, 16:42
XERS Xeris Biopharma Holdings, Inc. 31 Jan 2024 1 $0 4 Senior Vice President, Global Development and Medical Affairs 31 Jan 2024, 17:04
XERS Xeris Biopharma Holdings, Inc. 31 Jan 2023 1 $0 4 Senior Vice President, Global Development and Medical Affairs 01 Feb 2023, 15:12
XERS Xeris Biopharma Holdings, Inc. 29 Jan 2022 8 -$146,264 4 Senior Vice President, Global Development and Medical Affairs 09 Aug 2024, 16:07
XERS Xeris Biopharma Holdings, Inc. 03 Jan 2022 1 $0 4 Senior Vice President, Global Development and Medical Affairs 05 Jan 2022, 17:17
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 8 $0 4 Senior Vice President, Global Development and Medical Affairs 05 Oct 2021, 19:38
/report/000089924321039246-johnson-kenneth-erland-2021-10-05 XERIS PHARMACEUTICALS INC 05 Oct 2021 8 $0 4 Sr. VP Clinical Development, Regulatory, Quality Assurance & Medical Affairs 05 Oct 2021, 17:33
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 0 $0 3 Title: Senior Vice President, Global Development and Medical Affairs Exhibit 24 - Power of Attorney 05 Oct 2021, 17:18